News Eterna Therapeutics Inc.

Equities

ERNA

US1140822099

Market Closed - Nasdaq Other stock markets 04:30:01 2024-05-10 pm EDT			5-day change	1st Jan Change
2.02 ^USD	-6.48%		+8.90%	+12.54%

May. 08	Eterna Therapeutics Inc. Appoints Mahendra Rao to Its Scientific Advisory Board	CI
May. 07	Eterna Therapeutics Inc. to Present at the ASGCT 27Th Annual Meeting on Development of Beta 2 Microglobulin-Knockout (B2M-KO) iMSC Line	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Eterna Therapeutics Announces Appointment of Mahendra Rao, PhD, to its Scientific Advisory Board	May. 08	AQ
Eterna Therapeutics Inc. Appoints Mahendra Rao to Its Scientific Advisory Board	May. 08	CI
Eterna Therapeutics to Present at the ASGCT 27th Annual Meeting on the Development of a mRNA-Engineered iPSC Line which Mimics Native B2M Expression, via Targeted Insertion of HLA-E at the B2M Locus	May. 07	AQ
Eterna Therapeutics to Present at the ASGCT 27th Annual Meeting on Development of Beta 2 Microglobulin-Knockout (B2M-KO) iMSC Line with Enhanced Immunosuppressive Activity and Stealthing Features that May Further Augment the Therapeutic Potential of MSCs in Inflammatory Diseases	May. 07	AQ
Eterna Therapeutics Inc. to Present at the ASGCT 27Th Annual Meeting on Development of Beta 2 Microglobulin-Knockout (B2M-KO) iMSC Line	May. 07	CI
North American Morning Briefing : Inflation -2-	Mar. 15	DJ
Eterna Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 14	CI
Eterna Therapeutics Announces the Appointment of Peter Cicala, JD, to its Board of Directors	Feb. 20	AQ
Eterna Therapeutics Inc. Announces Appointment of Peter Cicala, JD to Its Board of Directors	Feb. 20	CI
Eterna Therapeutics Inc. Announces Appointment of Peter Cicala to the Board of the Audit Committee, the Compensation Committee and the Nominating and Corporate Governance Committee	Feb. 16	CI
Eterna Therapeutics Inc. Announces Management Changes	Jan. 19	CI
Eterna Therapeutics Grants New President and CEO Sanjeev Luther Inducement Award Under Nasdaq Listing Rule 5635 (c)(4)	Jan. 03	AQ
Eterna Therapeutics Inc Announces Chief Executive Officer Changes, Effective January 1, 2024	Dec. 20	CI
Eterna Therapeutics Inc Appoints Sanjeev Luther as President and Member of the Board of Directors, Effective January 1, 2024	Dec. 20	CI
Eterna Therapeutics Inc. Appoints James Bristol as Chairman of the Board	Dec. 20	CI
Eterna Therapeutics Names Sanjeev Luther as President and Chief Executive Officer	Dec. 20	AQ
Eterna Therapeutics Selling $9.2 Million of Convertible Promissory Notes, Accompanying Warrants	Dec. 15	MT
Eterna Therapeutics Announces $9.2 Million Convertible Debt and Warrant Financing	Dec. 14	AQ
Eterna Therapeutics Inc. announced that it expects to receive $9.2 million in funding	Dec. 13	CI
Eterna Therapeutics Inc. announced that it has received $1.5 million in funding	Dec. 07	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Eterna Therapeutics Inc.

Equities

ERNA

US1140822099

Summary

Filters